Steve B Cohen

Title: The Innovations of Steve B Cohen

Introduction

Steve B Cohen is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody antagonists. With a total of 2 patents, Cohen's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Cohen's latest patents include groundbreaking inventions such as PCSK9 antagonists. This invention provides antibody antagonists against proprotein convertase subtilisin/kexin type 9a (PCSK9) and outlines methods for using these antibodies. Another significant patent is for antagonists of protease activated receptor-1 (PAR1). This invention offers antibodies or antigen-binding molecules that specifically recognize and antagonize the human PAR1 receptor. Additionally, it includes polynucleotides and vectors that encode such molecules, as well as host cells that harbor these polynucleotides or vectors.

Career Highlights

Throughout his career, Cohen has worked with prominent companies such as Irm LLC and Novartis AG. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the biotechnology sector.

Collaborations

Cohen has collaborated with talented individuals in his field, including Sarah Rue and Jun Li. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Steve B Cohen's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.